Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 3
2005 3
2006 3
2007 4
2008 3
2009 3
2010 2
2011 5
2012 4
2013 4
2014 3
2015 5
2016 2
2017 5
2018 1
2019 2
2020 6
2021 11
2022 7
2023 17
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Results by year

Filters applied: . Clear all
Page 1
Selective PDE4 subtype inhibition provides new opportunities to intervene in neuroinflammatory versus myelin damaging hallmarks of multiple sclerosis.
Schepers M, Paes D, Tiane A, Rombaut B, Piccart E, van Veggel L, Gervois P, Wolfs E, Lambrichts I, Brullo C, Bruno O, Fedele E, Ricciarelli R, Ffrench-Constant C, Bechler ME, van Schaik P, Baron W, Lefevere E, Wasner K, Grünewald A, Verfaillie C, Baeten P, Broux B, Wieringa P, Hellings N, Prickaerts J, Vanmierlo T. Schepers M, et al. Among authors: brullo c. Brain Behav Immun. 2023 Mar;109:1-22. doi: 10.1016/j.bbi.2022.12.020. Epub 2022 Dec 28. Brain Behav Immun. 2023. PMID: 36584795 Free article.
Nanotechnology for Pediatric Retinoblastoma Therapy.
Russo E, Spallarossa A, Tasso B, Villa C, Brullo C. Russo E, et al. Among authors: brullo c. Pharmaceuticals (Basel). 2022 Aug 31;15(9):1087. doi: 10.3390/ph15091087. Pharmaceuticals (Basel). 2022. PMID: 36145308 Free PMC article. Review.
Pyrrolo[2,3-d]Pyrimidines as Kinase Inhibitors.
Musumeci F, Sanna M, Grossi G, Brullo C, Fallacara AL, Schenone S. Musumeci F, et al. Among authors: brullo c. Curr Med Chem. 2017;24(19):2059-2085. doi: 10.2174/0929867324666170303162100. Curr Med Chem. 2017. PMID: 28266267 Review.
An Update on JAK Inhibitors.
Musumeci F, Greco C, Giacchello I, Fallacara AL, Ibrahim MM, Grossi G, Brullo C, Schenone S. Musumeci F, et al. Among authors: brullo c. Curr Med Chem. 2019;26(10):1806-1832. doi: 10.2174/0929867325666180327093502. Curr Med Chem. 2019. PMID: 29589523 Review.
Amino-Pyrazoles in Medicinal Chemistry: A Review.
Lusardi M, Spallarossa A, Brullo C. Lusardi M, et al. Among authors: brullo c. Int J Mol Sci. 2023 Apr 25;24(9):7834. doi: 10.3390/ijms24097834. Int J Mol Sci. 2023. PMID: 37175540 Free PMC article. Review.
The Development of FAK Inhibitors: A Five-Year Update.
Spallarossa A, Tasso B, Russo E, Villa C, Brullo C. Spallarossa A, et al. Among authors: brullo c. Int J Mol Sci. 2022 Jun 7;23(12):6381. doi: 10.3390/ijms23126381. Int J Mol Sci. 2022. PMID: 35742823 Free PMC article. Review.
Indole Antitumor Agents in Nanotechnology Formulations: An Overview.
Russo E, Grondona C, Brullo C, Spallarossa A, Villa C, Tasso B. Russo E, et al. Among authors: brullo c. Pharmaceutics. 2023 Jun 25;15(7):1815. doi: 10.3390/pharmaceutics15071815. Pharmaceutics. 2023. PMID: 37514002 Free PMC article. Review.
New Insights on Fak and Fak Inhibitors.
Brullo C, Tasso B. Brullo C, et al. Curr Med Chem. 2021;28(17):3318-3338. doi: 10.2174/0929867327666201103162239. Curr Med Chem. 2021. PMID: 33143618 Review.
The Development of BTK Inhibitors: A Five-Year Update.
Tasso B, Spallarossa A, Russo E, Brullo C. Tasso B, et al. Among authors: brullo c. Molecules. 2021 Dec 6;26(23):7411. doi: 10.3390/molecules26237411. Molecules. 2021. PMID: 34885993 Free PMC article. Review.
88 results